Amsterdam, The Netherlands
We are a Venture Capital fund that invests in biotech companies developing drugs in a specialised area of disease: neurodegeneration, with a particular focus on ALS
7
Total Investments
6
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Biotechnology
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About ALS Investment Fund
Recent Investments (7)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Nov 2023 | |
| Series B | •••••• | Dec 2021 | |
| Series A | •••••• | Jan 2019 | |
| Series A | •••••• | Jul 2018 | |
| Series C | •••••• | Jun 2018 | |
•••• ••••
|
Venture Round | •••••• | Mar 2017 |
|
•••• ••••
|
Series A | •••••• | Aug 2016 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
